GAMMA Investing LLC Buys 2,892 Shares of AdaptHealth Corp. $AHCO

GAMMA Investing LLC grew its position in AdaptHealth Corp. (NASDAQ:AHCO) by 38.7% in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 10,365 shares of the company’s stock after buying an additional 2,892 shares during the quarter. GAMMA Investing LLC’s holdings in AdaptHealth were worth $98,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently made changes to their positions in the company. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its position in AdaptHealth by 21.8% in the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 197,901 shares of the company’s stock valued at $1,884,000 after buying an additional 35,431 shares in the last quarter. Reinhart Partners LLC. lifted its stake in shares of AdaptHealth by 15.5% in the 1st quarter. Reinhart Partners LLC. now owns 7,236,262 shares of the company’s stock valued at $78,441,000 after acquiring an additional 969,408 shares during the last quarter. Harbor Capital Advisors Inc. lifted its stake in shares of AdaptHealth by 23.5% in the 1st quarter. Harbor Capital Advisors Inc. now owns 586,443 shares of the company’s stock valued at $6,357,000 after acquiring an additional 111,721 shares during the last quarter. SummerHaven Investment Management LLC increased its holdings in AdaptHealth by 1.7% in the 1st quarter. SummerHaven Investment Management LLC now owns 79,883 shares of the company’s stock worth $866,000 after purchasing an additional 1,329 shares in the last quarter. Finally, Janney Montgomery Scott LLC acquired a new position in AdaptHealth in the 1st quarter worth about $854,000. 82.67% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In related news, Director David Solomon Williams III sold 8,200 shares of the company’s stock in a transaction on Friday, August 22nd. The shares were sold at an average price of $9.73, for a total value of $79,786.00. Following the completion of the transaction, the director directly owned 50,045 shares in the company, valued at approximately $486,937.85. The trade was a 14.08% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. 1.55% of the stock is owned by corporate insiders.

Analyst Ratings Changes

A number of analysts recently weighed in on the company. Wall Street Zen upgraded AdaptHealth from a “hold” rating to a “buy” rating in a report on Saturday, August 9th. Zacks Research lowered shares of AdaptHealth from a “hold” rating to a “strong sell” rating in a report on Friday, September 19th. Five equities research analysts have rated the stock with a Buy rating and one has given a Sell rating to the stock. Based on data from MarketBeat, AdaptHealth has a consensus rating of “Moderate Buy” and an average price target of $13.40.

AdaptHealth Price Performance

AdaptHealth stock opened at $9.11 on Thursday. AdaptHealth Corp. has a one year low of $7.11 and a one year high of $11.63. The business has a fifty day moving average price of $9.25 and a 200-day moving average price of $9.13. The company has a debt-to-equity ratio of 1.14, a current ratio of 1.06 and a quick ratio of 0.82. The firm has a market capitalization of $1.23 billion, a P/E ratio of 16.87, a PEG ratio of 1.00 and a beta of 1.62.

AdaptHealth Company Profile

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.